[PDF] Top 20 Parkinson’s Disease-A Case Study

... The patient is a Vietnam veteran working as a computer specialist who at the age of 55 years began to experience tremor in the left upper extremity, which led to the diagnosis of Parkinson’s disease. The patient ... See full document

... In clinical practice, the assessment of postural control is based on neurological examination, including the Romberg test, pull test and gait examination, but all of them are quantitative methods and techniques for the ... See full document

... doses, teprenone 150 mg in 3 divided doses, and loxo- profen 180 mg in 3 divided doses. General examination revealed no abnormalities except for the bilateral an- terior thoracic DBS generators. On neurological exam- ... See full document

... Subjects were randomly assigned to either 1 mg/day rasagiline, 200 mg entacapone with every levodopa dose, or placebo. Levodopa dosage could be reduced in the initial 6 weeks but no change could be made subsequently. The ... See full document

... One study found that the use of modafinil used adjunctively with CPAP improved subjective daytime sleepiness in PD patients suffering from sleep apnea compared to treatment with CPAP ... See full document

... Parkinson’s disease (PD) is one of the most frequent neurological ...the disease management often complicated even when the presence of PD seems ...the disease, especially with the progressive effect ... See full document

... We will minimise reporting biases (publication bias, time lag bias, duplicate publication bias, location bias, citation bias, language bias or outcome reporting bias) through a comprehensive search for studies, inclusion ... See full document

... present study corroborates that FOF restricts participation in meaningful activ- ities ...previous study of persons with PD did not report FOF as impacting on their decision to engage in physical exercise ... See full document

... ’ s QoL is a crucial goal for clinicians involved in rehabilitative ...with Parkinson ’ s Disease (PD), in this study we have first translated and then validated the ... See full document

... Diagnosis of PD was made according to the U.K. PD Brain Bank criteria. PD patients suffering from diseases known to influence the urinary function, i.e. cognitive impairment, major depression and other psychiatric dis- ... See full document

... SWITCH study aimed at determining if switching from entacapone to tolcapone might improve patient outcomes (SWITCH ...active-control study conducted at 32 centers in Europe and the US, enrolling 150 ... See full document

... to have a major impact throughout the course of the disease. A number of clinical subtypes with differing NMS patterns have been established, which feature the early, untreated phase of the disease. This ... See full document

... In the past few years, the field of miRNA study has revealed highly significant molecular mechanisms relevant to PD pathogenesis. Emerging evidence strongly indicates the important role of miRNAs in the ... See full document

... This study provides welcome Class 1 evidence that these commonly used medications, both of which have safety profiles offering the considerable advantages of TCAs, are effective in ...this study also ... See full document

... PRESTO study (Parkinson’s Rasagiline: Efficacy and Safety in the Treatment of “Off ”) was a randomized, placebo-controlled, double-blind trial of subjects with advanced PD with motor ... See full document

... articles, case reports, letters to the editor, clinical teaching cases, neuroradiology highlights, neuropathol- ogy highlights, neuropsychiatry highlights, autobiographies, conference ... See full document

... Another matter of controversy is the possible advantage of extended olfactory and/or parallel testing to improve diag- nostic performance. One study assessed whether extended olfactory testing can increase ... See full document

... Hoehn and Yahr stage was II–V for the PD group and the MSA group comprised 20 probable and 7 possible MSA. Spirometry showed a restrictive pattern in 56.7% of PD patients (63% MSA), central obstructive in 3.3% PD (0% ... See full document

... Results: Patients (60.7% men) were aged 68.02±7.43 years. PD duration was 12.57±5.97 years. Median Hoehn and Yahr (HY) stage of patients in “ on ” was 2 (range: 1 – 4). There were excellent data quality and acceptability ... See full document

... several study limitations. The small sample size of this study may have affected the study findings and limits their ...pilot study will lead to a better-designed RCT and serve as a discussion ... See full document